ANDA 63304, held by Xttrium Labs Inc. Clindamycin Phosphate.
As of Nov 15, 2026, ANDA 63304 (Clindamycin Phosphate), held by Xttrium Labs Inc, was first approved by FDA on Jul 15, 1997, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 15, 1997 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clindamycin PhosphateEQ 1% BASE ยท solution;topical | Clindamycin Phosphate | Discontinued |
| May 15, 2001 | Supplement 3Manufacturing | Approved | None posted |
| May 15, 2001 | Supplement 4Manufacturing | Approved | None posted |
| Apr 3, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Jul 15, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters